tradmap

ALGN Align Technology

$151.59 -1.68%

Data as of close

S&P 500 Companies

Held by SPYVOOIVV

Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Align Technology (ALGN) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $10.8 billion. Shares last traded at $151.59, 24.4% below their 52-week high. Over the past year the stock is up 9.9%. ALGN trades at a price-to-earnings ratio of 26.04, in line with the Orthopedic, Prosthetic & Surgical Appliances & Supplies median of 26.04. Net profit margin is 10.0%, above the peer median of 5.3%. Revenue grew 0.9% year over year.

Market Cap
$10.8B
Shares Out
71.0M
EPS (TTM)
$5.74
P/E (TTM)*
26.04
P/S Ratio
2.60
P/B Ratio
2.54
Dividend / Share
—
Dividend Yield
—
52-Week High
$200.44
52-Week Low
$130.37
Volume (venue)
49,930
Avg Vol (3m, venue)
56,152.413

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-0.26%
1M
+7.78%
3M
-13.27%
6M
-10.21%
YTD
-2.94%
1Y
+9.89%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
52.10
SMA (50)
$150.15
SMA (200)
$168.67
Price vs SMA50
+0.96%
Price vs SMA200
-10.13%
ATR (14)
$4.62

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$4.1B
Net Income
$414M
Gross Margin
68.0%
Operating Margin
13.2%
Net Margin
10.0%
Return on Equity
9.8%
Return on Assets
6.4%
Current Ratio
1.40
Debt / Equity
0.52
Revenue Growth (YoY)
+0.9%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $1.51 2026-08-05
Q1 2026 $1.57 2026-05-06
Q4 2025 (derived) $1.88 2026-02-27
FY 2025 $5.65 2026-02-27
Q3 2025 $0.78 2025-11-05
Q2 2025 $1.72 2025-08-06

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Orthopedic, Prosthetic & Surgical Appliances & Supplies peers

ALGN vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap. Data as of close

P/E vs peers
26.04 / 26.04 med
+0% premium
P/S vs peers
2.60 / 2.65 med
-2% discount
Net margin vs peers
10.0% / 5.3% med
above median
1–14 of 14
ISRGIntuitive Surgical$152.8B51.6613.1925.5%+0.90%
EWEdwards Lifesciences$54.9B54.618.4315.4%+2.09%
STESteris$22.5B27.993.7313.3%-0.93%
ZBHZimmer Biomet$18.5B22.952.189.5%-0.26%
ALGNAlign Technology$10.8B26.042.6010.0%-1.68%
MSAMsa Safety Inc$6.7B22.183.3315.0%-6.82%
ESTAEstablishment Labs Holdings Inc.$1.8B—7.44-15.8%+0.52%
CDRECadre Holdings, Inc.$1.3B36.921.945.3%-1.44%
ENOVEnovis Corp$1.2B—0.52-48.0%+1.24%
AVRAnteris Technologies Global Corp.$546M—243.43—-2.95%
SMTISanara MedTech Inc.$296M—2.69-29.2%+0.00%
INGNInogen Inc$187M—0.61-8.1%+2.33%
LAKELAKELAND INDUSTRIES INC$89M—0.46-14.0%-0.11%
NTRBNutriBand Inc.$77M———+1.03%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.